Serum CXCL6 was higher in ANCA-associated vasculitis with interstitial lung disease and independently predicted ILD progression, suggesting a blood biomarker to identify AAV-ILD and monitor risk.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback